Dr. Henry A. Mentz , MD
Specialist • Houston, TX
4400 Post Oak Pkwy, Suite 2260
Houston, TX 770273421
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on November 21, 2006; this date does not establish years in practice.
-
Published CMS data list 319 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Cephalexin — 48 prescription fills, including refills.
- Ondansetron Hcl — 47 prescription fills, including refills.
- Methylprednisolone — 44 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 10 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Part D prescriptions among clinicians listed under Specialist in Houston, TX (2024, 66 clinicians with data). Median for this group: 357. Middle half: 109 to 1,104.
Close to the middle for Part D prescriptions among clinicians listed under Specialist in Texas (2024, 359 clinicians with data). Median for this group: 461. Middle half: 86 to 1,434.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 136 in 2020 to 319 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
4400 Post Oak Pkwy
Suite 2260
Houston, TX 770273421
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
320 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$3,055 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $4,661.26 across 46 records.
By nature of payment
- Food and Beverage: $3,161.26 across 44 records.
- Consulting Fee: $1,500.00 across 2 records.
Reporting-company totals (3 largest of 6)
- Integra LifeSciences Corporation: $1,568.24 across 4 records.
- MOTIVA USA, LLC: $1,336.45 across 15 records.
- REVANCE THERAPEUTICS, INC.: $1,323.52 across 17 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Can order Medicare-covered services
CMS lists Dr. Mentz as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Houston and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Specialist in Houston, TX (2024, 66 clinicians with data). Median for this group: 357. Middle half: 109 to 1,104.
Close to the middle for clinicians listed under Specialist in Texas (2024, 359 clinicians with data). Median for this group: 461. Middle half: 86 to 1,434.
Part D drug cost
A lower Part D drug cost than 65% of clinicians listed under Specialist in Houston, TX (2024, 66 clinicians with data). Median for this group: $35,905. Middle half: $1,256 to $190,940.
A lower Part D drug cost than 65% of clinicians listed under Specialist in Texas (2024, 359 clinicians with data). Median for this group: $19,874. Middle half: $1,229 to $181,992.
267 active clinicians are listed under Specialist with a practice address in Houston, TX (1,710 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Houston
3.4% of these 267 clinicians have the CMS telehealth indicator.
18.7% of these 267 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 135% from 136 in 2020 to 319 in 2024.
- 2020: 136
- 2021: 211
- 2022: 252
- 2023: 259
- 2024: 319
-
30-day fills
30-day fills increased 136% from 136 in 2020 to 320 in 2024.
- 2020: 136
- 2021: 211
- 2022: 252
- 2023: 259
- 2024: 320
-
Part D drug cost
Part D drug cost increased 155% from $1,196 in 2020 to $3,055 in 2024.
- 2020: $1,196
- 2021: $3,454
- 2022: $3,243
- 2023: $2,732
- 2024: $3,055
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 19% from $3,920.75 in 2021 to $4,661.26 in 2025.
- 2021: $3,920.75
- 2022: $1,159.55
- 2023: $4,433.81
- 2024: $7,775.26
- 2025: $4,661.26
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 46 records totaling $4,661.26.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Integra LifeSciences Corporation |
Consulting Fee
Cash or cash equivalent
|
CODMAN CERTAS | General | $1,000.00 |
| Integra LifeSciences Corporation |
Consulting Fee
Cash or cash equivalent
|
OMNIGRAFT | General | $500.00 |
| MOTIVA USA, LLC |
Food and Beverage
Cash or cash equivalent
|
Motiva Implant Matrix | General | $172.76 |
| MOTIVA USA, LLC |
Food and Beverage
Cash or cash equivalent
|
Motiva Implant Matrix | General | $169.72 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $149.03 |
| MOTIVA USA, LLC |
Food and Beverage
Cash or cash equivalent
|
Motiva Implant Matrix | General | $146.93 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $145.92 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $141.30 |
| Mentor Worldwide LLC |
Food and Beverage
In-kind items and services
|
MENTOR MemoryGel Resterilizable Gel Sizer | General | $128.56 |
| MOTIVA USA, LLC |
Food and Beverage
Cash or cash equivalent
|
Motiva Implant Matrix | General | $125.00 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $111.11 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
NATRELLE SALINE-FILLED BREAST IMPLANTS | General | $107.25 |
| MOTIVA USA, LLC |
Food and Beverage
Cash or cash equivalent
|
Motiva Implant Matrix | General | $105.80 |
| MOTIVA USA, LLC |
Food and Beverage
Cash or cash equivalent
|
Motiva Implant Matrix | General | $88.48 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $86.10 |
| MOTIVA USA, LLC |
Food and Beverage
Cash or cash equivalent
|
Motiva Implant Matrix | General | $79.92 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
ALLODERM | General | $79.33 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $79.17 |
| MOTIVA USA, LLC |
Food and Beverage
Cash or cash equivalent
|
Motiva Implant Matrix | General | $75.98 |
| MOTIVA USA, LLC |
Food and Beverage
Cash or cash equivalent
|
Motiva Implant Matrix | General | $75.00 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $72.89 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $71.25 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $71.25 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $64.02 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $61.18 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Cephalexin | Cephalexin | 48 | 251 | $141.70 | 43 |
| Ondansetron Hcl | Ondansetron Hcl | 47 | 347 | $246.75 | 46 |
| Methylprednisolone | Methylprednisolone | 44 | 265 | $268.39 | 44 |
| Alprazolam | Alprazolam | 44 | 277 | $151.19 | 44 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 37 | 228 | $458.52 | 34 |
| Famciclovir | Famciclovir | 25 | 214 | $523.36 | 22 |
| Clonidine | Clonidine | 23 | 625 | $899.86 | 23 |
| Mupirocin | Mupirocin | 22 | 516 | $217.17 | 22 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 16 | 95 | $111.96 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 92 | $35.60 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSSources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Specialist
Doctor of Medicine (M.D.)
Plastic Surgery
Doctor of Medicine (M.D.)
Specialist
Doctor of Medicine (M.D.)
Surgery - Plastic and Reconstructive Surgery
Doctor of Medicine (M.D.)
Specialist
Doctor of Medicine (M.D.)
Plastic Surgery
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated November 21, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Specialists in Houston
- Dr. Mark Skellenger, MD
- Dr. Ronald Rance, MD
- Dr. Mary Parker, MD
- Dr. Claire Ozaki, MD
- Dr. Mark Schusterman, MD
- Dr. Carlos Gonzalez, MD
Mailing Address
12727 Kimberley Ln, Suite 300
Houston, TX 770244047
Phone: 7137999999